Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Respiratory Tract Infections, Date of authorisation: 27/10/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Respiratory Tract Infections, Date of authorisation: 27/10/2020, Revision: 2, Status: Authorised Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Respiratory Tract Infections, Date of authorisation: 27/10/2020, Revision: 2, Status: Authorised Lees verder » Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Respiratory Tract Infections;Cystic Fibrosis, Date of authorisation: 18/02/2019, Revision: 4, Status: Authorised Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Respiratory Tract Infections;Cystic Fibrosis, Date of authorisation: 18/02/2019, Revision: 4, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.  Volg ons! Nieuwsbrief Twitter Facebook Stel jouw vraag aan de redactie! Naam E-mail * Bericht * Handige Sites De Duurzame Wereld Zonne-energieSector WindenergieSector Autoliefhebber.eu I Ondernemer De Fiere Fries  Vlaams Nieuws De Nederlandse Vereniging   De OnderwijsSector CryptoSector BitcoinSector CardanoSector EthereumSector TerraSector StablecoinSector Privacybeleid Lees verder Wordt geladen...